Skip to main content

Table 2 Different expression peptides between newly diagnosed AML group and healthy control group

From: Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Index

Mass

Dave

P value

Ave1

Ave2

StdDev1

StdDev2

Expression change

48

4208.76

29.66

0.00000192

10.64

40.31

10.37

13.98

↓

12

1866.09

18.67

0.000489

22.08

3.41

25.9

1.6

↑

60

5902.57

16.49

0.0000421

10.02

26.51

9.35

11.59

↓

64

6628.07

9.4

0.00000388

13.85

4.45

7.71

3.24

↑

69

9286.53

7.84

0.00000192

2.34

10.19

2.03

4.38

↓

34

3262.18

7.49

0.0000723

5.78

13.27

7.05

6.55

↓

42

4089.7

7.39

0.00000108

2.69

10.08

1.39

4.03

↓

66

7762.87

6.42

0.00000108

1.94

8.36

1.25

3.35

↓

4

1282.99

5.83

0.00000203

2.57

8.41

0.63

6.16

↓

52

4643.21

5.66

0.0000168

2.37

8.03

1.75

4.4

↓

5

1299.56

5.53

0.00000108

2.33

7.87

0.57

5.26

↓

30

2990.42

5.3

0.00000146

6.88

1.57

5.08

0.68

↑

36

3315.58

5.05

0.00000203

7.05

2

3.74

1.15

↑

31

3191.17

4.61

0.00000625

2.7

7.31

1.63

3.51

↓

19

2168.67

4.45

0.0000573

2.04

6.5

0.71

5.51

↓

39

3950.86

4.17

0.00000203

2.56

6.73

1.27

2.76

↓

20

2184.85

4.05

0.0116

2.54

6.59

1.06

5.72

↓

29

2952.24

4.03

0.00616

4.57

8.6

3.14

5.22

↓

47

4192.99

4.01

0.00000515

2.46

6.48

1.31

2.79

↓

18

2105.44

3.74

0.0000127

3.05

6.79

1.55

2.99

↓

56

5335.01

3.21

0.000605

3.42

6.62

2.95

3.29

↓

40

4052.81

3.07

0.000206

3.13

6.21

2.83

2.37

↓

62

6430.27

3.02

0.0000335

4.67

1.66

3.69

1.13

↑

2

1100.81

2.86

0.000259

2.62

5.48

1.01

3.23

↓

13

1982.13

2.55

0.000137

2.21

4.75

0.63

3.1

↓

37

3882.23

2.53

0.000257

2.19

4.73

1.01

2.17

↓

16

2062.28

2.38

0.0000723

1.69

4.07

0.45

2.68

↓

25

2768.83

2.28

0.00000108

1.81

4.09

0.51

1.52

↓

15

2037.71

2.26

0.0075

1.84

4.1

0.35

3.12

↓

17

2069.96

2.19

0.000749

2.02

4.21

0.46

2.65

↓

59

5864.9

2.18

0.000247

2.47

4.65

1.15

1.85

↓

53

4818.02

2.17

< 0.000001

2.68

0.51

3.32

0.18

↑

50

4265.7

1.88

0.000749

2.46

4.34

1.07

1.85

↓

14

2021.95

1.8

0.00326

4.64

2.84

2.37

3.02

↑

28

2932

1.59

0.000605

2.63

4.22

0.81

1.56

↓

46

4167.87

1.56

0.0000437

1.69

3.25

0.84

1.02

↓

41

4071.18

1.39

0.000029

1.53

2.92

0.38

0.94

↓

33

3240.42

1.23

0.00958

7.47

8.7

9.41

3.17

↓

65

6662.81

1.13

0.0000187

2.28

1.15

0.93

0.56

↑

61

5957.41

1.08

0.0000299

1.06

2.14

0.26

0.95

↓

32

3216.57

1.04

0.00357

2.87

1.83

1.45

0.53

↑

63

6526.9

0.79

0.00000268

1.37

0.58

0.52

0.25

↑

44

4121.48

0.78

0.000259

1.62

2.4

0.38

0.71

↓

38

3933.89

0.77

0.0000406

1.42

2.19

0.38

0.65

↓

21

2561.11

0.69

0.0309

2.59

1.9

1.27

0.63

↑

43

4108.19

0.66

0.000357

1.37

2.03

0.42

0.56

↓

45

4152.3

0.18

0.0206

2.41

2.22

2.65

0.68

↑

  1. Index peptide peak index, Mass mass to charge ratio value, Dave differences of average peak intensity between newly diagnosed AML group and healthy control group, P value p value of t-test, Ave1 average peak intensity of newly diagnosed AML group, Ave2 average peak intensity of healthy control group, StdDev1 standard deviation of the peak intensity average of newly diagnosed AML group, StdDev2 standard deviation of the peak intensity average of healthy control group.